ExonanoRNA is a biotechnology startup established in 2017, specializing in the design and production of RNA nanoparticles. The company aims to fill a market gap by commercially producing high-quality RNA nanoparticles for research and pre-clinical development. Their expertise lies in RNA nanotechnology which allows the integration of multiple functional RNA modules into one nanoparticle. The core activities of ExonanoRNA revolve around researching and developing innovative products in the RNA nanotechnology-based platforms for next-generation targeted drug delivery and disease diagnosis. The team, consisting of experienced scientists, efficiently coordinates a multidisciplinary effort to transition bio-nanotechnology, especially RNA nanotechnology, from the bench to the clinic. ExonanoRNA's slogan "We specialize in the design and production of RNA nanoparticles" encapsulates their specialization and expertise, positioning them as leaders in the field. Though no specific information about their headquarters location or previous investments is available, the potential for growth and impact in the biotechnology industry makes ExonanoRNA an intriguing prospect for venture capitalists looking to invest in innovative biotech startups.
There is no investment information
No recent news or press coverage available for ExonanoRNA.